null Coverage

A Quebec research network aims to protect seniors from respiratory virus: A team of Quebec researchers has just received joint funding of $12.3 million from the Ministère des Finances and de l'Économie and Medicago Inc. for their work to develop innovative vaccines.

AmorChem invests in potential therapy for late-stage breast cancer: AmorChem is investing in a project focused on the work of Dr. Pnina Brodt, professor in the Departments of Surgery, Medicine and Oncology at McGill University and a researcher of the Cancer Axis at the Research Institute of the McGill University Health Centre (RI-MUHC).

Merck invests in Montréal's life sciences research sector: A $12.5 million contribution will fund academic and hospital-affiliated research institutions.